
Neogen Corporation
Neogen Corporation is a United States-based company in the Healthcare sector with a market capitalisation of $2.6B. Its FinScore is 40/100; its highest-scoring layer is Momentum (62) and its lowest is Quality (31).
Share price performance
About Neogen Corporation
www.neogen.comNeogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.
- Sector
- Healthcare
- Industry
- Medical - Devices
- HQ
- United States
- Fiscal year-end
- May
- Trading currency
- USD
- Reporting currency
- USD
- Fundamentals updated
- 2 days ago
- Market cap
- $2.6B
- Shares outstanding
- 218.3M
- Beta (issuer)
- 1.79
- Revenue (latest FY)
- $870.4M
Revenue breakdown
- Product88.3%$768.2M
- Service11.7%$102.2M
FinScore
As of 2026-10-19Snapshot
Ownership
As of 2026-06-30Sign up or log in to see Analysis
Analysis for Neogen Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Neogen Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Neogen Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Neogen Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Neogen Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Neogen Corporation is available to Finryse members. The Overview stays open to everyone; creating an account is free.